Open AccessP695: PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN CHRONIC PHASE CML
Author(s) -
Bidikian A.,
Kantarjian H.,
Jabbour E.,
Short N.,
Ravandi F.,
Issa G.,
Sasaki K.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845664.41918.94
Subject(s) - dasatinib , medicine , oncology , myeloid leukemia , discontinuation , nilotinib , bosutinib , imatinib , univariate analysis , ponatinib , multivariate analysis